AstraZeneca vaccine as third dose effective against Omicron, says study

Results were observed among individuals previously vaccinated with either Vaxzevria or an mRNA vaccine

AstraZeneca vaccine as third dose effective against Omicron, says study

Photo for representational purpose only. Reuters file

PTI

London, January 13

The AstraZeneca Vaxzevaria vaccine showed an increased antibody response to the Omicron variant of COVID-19 after a third booster dose, preliminary data released by the Anglo-Swedish biopharma major said on Thursday.

In an ongoing safety and immunogenicity trial of the vaccine, a formulation developed by Oxford University and administered in India as Covishield, it was found that given as a third dose increased the body’s immune response to Beta, Delta, Alpha and Gamma SARS-CoV-2 variants.

A separate analysis of samples from the trial showed increased antibody response to the Omicron variant. The results were observed among individuals previously vaccinated with either Vaxzevria or an mRNA vaccine.

The company said it is submitting this additional data to health authorities around the world given the urgent need for third dose boosters.

Tribune Shorts


Top Stories

Covid deaths in third wave majorly lower than second due to high vaccine uptake

Covid deaths in third wave majorly lower than second due to high vaccine uptake

Bed occupancy in Delhi stable despite rise in new and active...

SC upholds 27 pc OBC reservation in NEET all-India quota

SC upholds 27 pc OBC reservation in NEET all-India quota

Top court says challenge to the validity of criteria for det...

Maharashtra to reopen schools from Monday as Omicron cases fall

Maharashtra to reopen schools from Monday as Omicron cases fall

Schools from Grade 1 to Grade 12 to reopen, says education m...

China's PLA abducts boy from inside Indian territory in Arunachal Pradesh, says state MP Tapir Gao

Indian Army seeks assistance from PLA to locate and return missing Arunachal youth

Arunachal Pradesh's MP Tapir Gao said on Wednesday that PLA ...

Cities

View All